Metrion Biosciences will be attending ELRIG Drug Discovery 2019 to be held at the ACC Arena, Liverpool on 5th and 6th November 2019. Please email info@metrionbiosciences.com if you would like to arrange a meeting with Metrion's representatives. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s [...]
Metrion Biosciences' CSO Dr Marc Rogers will be presenting a drug discovery focused talk at the Pain and Migraine Therapeutics Summit in Washington DC on 23rd to 24th September 2019. Marc will also be available during both days of the conference to discuss Metrion's range of ion channel focused drug discovery services. If you would [...]
Metrion Biosciences' Dr Sophie Rose will be attending On Helix at the Cambridge Building, Babraham Research Campus on Tuesday 9th July and participating in the panel discussion ‘Communication of the Future’. Sophie will also be on hand both before and after the panel discussion to provide more information on Metrion's range of ion channel drug [...]
Sophie Rose will be attending the Milner Therapeutic Symposium hosted by the Milner Institute at the Corn Exchange Cambridge on Tuesday 25th June 2019. This symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma or biotech towards new treatments. Please email [...]
Metrion Biosciences will be attending the annual Ion Channel Modulation Symposium (ICMS) organised by Sophion Bioscience on Thursday 20th and Friday 21st June 2019. The meeting will take place at Clare College, Memorial Court, Cambridge. Metrion will be presenting a poster (title and presenter to be confirmed) and will also be attending the dinner on [...]
Metrion Biosciences' CEO Dr Andrew Southan and Sales and Marketing Manager Dr Sophie Rose will be attending Biotech Outsourcing Strategy in Basel, Switzerland on Wednesday 19th and Thursday 20th June 2019. Metrion have a ten minute presentation slot at 11.20-11.30 on Day 1 (Wednesday 19th June) during the Discovery Track: "Innovation and Excellence in Discovery [...]
Metrion Biosciences' Sales and Marketing Manager Dr Sophie Rose will be attending ELRIG Advances in Cell Based Screening hosted by The ELRIG Committee and AstraZeneca in Molndal, Sweden from Wednesday 22nd to Thursday 23rd May 2019. Sophie will be available to discuss Metrion's range of ion channel drug discovery services. Please email: info@metrionbiosciences.com if you [...]
Metrion Biosciences' Sophie Rose and John Ridley will be attending ELRIG Research and Innovation 2019 to be held at Homerton College, Cambridge on Tuesday 2nd and Wednesday 3rd April. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the [...]
Metrion Biosciences' Sophie Rose will be attending the Journey of Biopharmaceutical Innovation sponsored by One Nucleus, on Friday 25th January held at the Royal College Of Physicians (11 Saint Andrews PlaceNW1 4LE London, London, England, GB). Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest [...]
Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services Agreement enables customers to access a broader range of drug discovery expertise. Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, and AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve [...]
